BCM
OSTX

Bridgeway Capital Management’s OS Therapies Inc OSTX Stock Holding History

Bridgeway Capital Management’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.5K Buy
45,000
+20,000
+80% +$33.5K ﹤0.01% 1161
2026
Q1 		$35.3K Hold
25,000
– – ﹤0.01% 1197
2025
Q4 		$35K Hold
25,000
– – ﹤0.01% 1195
2025
Q3 		$49K Hold
25,000
– – ﹤0.01% 1170
2025
Q2 		$47K Buy
+25,000
New +$42.1K ﹤0.01% 1138

Other funds holding OSTX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bridgeway Capital Management's OSTX Position: Q2 2026 in Review

Bridgeway Capital Management increased its OS Therapies Inc (OSTX) stake by 80% in Q2 2026, buying an estimated $33.5K and bringing the position to 45,000 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

Bridgeway Capital Management first reported a position in OSTX in Q2 2025 and has held it in 5 quarters since. 29 funds tracked by Wall St. Rank hold OSTX as of Q2 2026.

  • Bridgeway Capital Management held 45,000 shares of OS Therapies Inc worth $85.5K as of Q2 2026.
  • Bridgeway Capital Management bought 20,000 OS Therapies Inc shares in Q2 2026, an estimated $33.5K.
  • OS Therapies Inc made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1161 holding.
  • Bridgeway Capital Management first reported a position in OS Therapies Inc in Q2 2025 and has held it in 5 quarters since.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.